Ersi Voskaridou

4.3k total citations
123 papers, 2.8k citations indexed

About

Ersi Voskaridou is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Ersi Voskaridou has authored 123 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Genetics, 72 papers in Hematology and 22 papers in Oncology. Recurrent topics in Ersi Voskaridou's work include Hemoglobinopathies and Related Disorders (98 papers), Iron Metabolism and Disorders (51 papers) and Blood groups and transfusion (31 papers). Ersi Voskaridou is often cited by papers focused on Hemoglobinopathies and Related Disorders (98 papers), Iron Metabolism and Disorders (51 papers) and Blood groups and transfusion (31 papers). Ersi Voskaridou collaborates with scholars based in Greece, United States and Italy. Ersi Voskaridou's co-authors include Evangelos Terpos, Dimitris Loukopoulos, Dimitrios Christoulas, Ioannis Papassotiriou, Aphrodite Loutradi, Eleni Plata, Klio Sinopoulou, Konstantinos Varvagiannis, Antonios Bilalis and G. Stamatopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Ersi Voskaridou

116 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ersi Voskaridou Greece 28 2.2k 1.8k 532 423 394 123 2.8k
Paolo Cianciulli Italy 23 1.4k 0.6× 1.2k 0.7× 283 0.5× 45 0.1× 202 0.5× 57 2.0k
Holger Cario Germany 19 890 0.4× 680 0.4× 187 0.4× 110 0.3× 440 1.1× 72 1.5k
Dimitrios Christoulas Greece 22 608 0.3× 1.2k 0.7× 167 0.3× 642 1.5× 600 1.5× 89 1.6k
Nicola Conran Brazil 25 1.5k 0.7× 1.1k 0.6× 190 0.4× 45 0.1× 423 1.1× 105 2.0k
Johan Lanng Nielsen Denmark 24 418 0.2× 1.3k 0.7× 89 0.2× 774 1.8× 612 1.6× 63 2.0k
Ron Hoffman Israel 22 896 0.4× 757 0.4× 64 0.1× 235 0.6× 633 1.6× 48 2.2k
Shirley D’Sa United Kingdom 25 758 0.3× 1.4k 0.8× 64 0.1× 628 1.5× 469 1.2× 122 2.4k
Wynona Coles United States 14 2.1k 1.0× 1.6k 0.9× 402 0.8× 24 0.1× 298 0.8× 28 2.5k
Laura Sainati Italy 26 812 0.4× 600 0.3× 258 0.5× 135 0.3× 312 0.8× 86 1.7k
Valeria Maria Pinto Italy 19 648 0.3× 527 0.3× 131 0.2× 96 0.2× 115 0.3× 57 1.0k

Countries citing papers authored by Ersi Voskaridou

Since Specialization
Citations

This map shows the geographic impact of Ersi Voskaridou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ersi Voskaridou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ersi Voskaridou more than expected).

Fields of papers citing papers by Ersi Voskaridou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ersi Voskaridou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ersi Voskaridou. The network helps show where Ersi Voskaridou may publish in the future.

Co-authorship network of co-authors of Ersi Voskaridou

This figure shows the co-authorship network connecting the top 25 collaborators of Ersi Voskaridou. A scholar is included among the top collaborators of Ersi Voskaridou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ersi Voskaridou. Ersi Voskaridou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Habibi, Anoosha, Giovanna Cannas, Pablo Bartolucci, et al.. (2023). Outcomes of Pregnancy in Sickle Cell Disease Patients: Results from the Prospective ESCORT-HU Cohort Study. Biomedicines. 11(2). 597–597. 13 indexed citations
3.
Habibi, Anoosha, Maryse Etienne‐Julan, Emmanuelle Bernit, et al.. (2023). Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies. Blood. 142(Supplement 1). 2500–2500.
4.
Montalembert, Mariane de, Ersi Voskaridou, Lena Oevermann, et al.. (2021). Real‐Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT‐HU cohort study. American Journal of Hematology. 96(10). 1223–1231. 34 indexed citations
5.
Papassotiriou, Ioannis, et al.. (2013). Targeted Metabolomic Profiles Are Strongly Correlated With Metabolic Alterations In Patients With Sickle Cell/Beta Thalassemia Disease. Blood. 122(21). 4675–4675. 2 indexed citations
6.
7.
Voskaridou, Ersi, D. Christoulas, Cornelia Bratengeier, et al.. (2012). High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density. Hormone and Metabolic Research. 44(12). 909–913. 47 indexed citations
8.
Voskaridou, Ersi, et al.. (2012). Co-Existence of Hereditary Pyrimidine 5-Nucleotidase Deficiency and Heterozygous α-Thalassemia: A Case Presentation. SHILAP Revista de lepidopterología. 29(4). 433–435. 1 indexed citations
9.
Terpos, Evangelos & Ersi Voskaridou. (2010). Treatment options for thalassemia patients with osteoporosis. Annals of the New York Academy of Sciences. 1202(1). 237–243. 53 indexed citations
10.
Voskaridou, Ersi, et al.. (2010). Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia. Annals of Hematology. 90(1). 11–15. 8 indexed citations
11.
Voskaridou, Ersi, Dimitrios Christoulas, Antonios Bilalis, et al.. (2009). The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood. 115(12). 2354–2363. 307 indexed citations
12.
13.
Voskaridou, Ersi, et al.. (2005). Osteoporosis in Sickle Cell/β-Thalassemia Is Primarily Caused by an Imbalance at the RANKL/OPG Pathway.. Blood. 106(11). 3173–3173. 1 indexed citations
14.
Terpos, Evangelos, Nora Viniou, Josu de la Fuente, et al.. (2003). Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin‐6 and β2‐microglobulin in multiple myeloma. European Journal Of Haematology. 70(1). 34–42. 43 indexed citations
15.
Andrikopoulos, Nikolaos K., et al.. (2002). Inverse correlation of plasma leptin and soluble transferrin receptor levels in β-thalassemia patients. Annals of Hematology. 81(9). 543–547. 13 indexed citations
16.
Papassotiriou, Ioannis, Ersi Voskaridou, Alexandra Stamoulakatou, & Dimitris Loukopoulos. (2000). Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patients. The Hematology Journal. 1(5). 295–300. 15 indexed citations
17.
Loukopoulos, Dimitris, et al.. (2000). Reduction of the Clinical Severity of Sickle Cell/β-Thalassemia with Hydroxyurea: The Experience of a Single Center in Greece. Blood Cells Molecules and Diseases. 26(5). 453–466. 34 indexed citations
18.
Voskaridou, Ersi, et al.. (1997). Cytogenetic and molecular studies in sickle cell patients receiving hydroxyurea over long time periods do not indicate an increased risk for leukemia. 2. 2915. 2 indexed citations
19.
Voskaridou, Ersi, et al.. (1995). Hb Lepore (Pylos)/Hb S compounds heterozygosity in two Greek families. American Journal of Hematology. 49(2). 131–134. 4 indexed citations
20.
Aessopos, Athanassios, et al.. (1994). Angioid Streaks in Sickle-Thalassemia. American Journal of Ophthalmology. 117(5). 589–592. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Cianciulli Breakdown of academic impact, for papers by Holger Cario Breakdown of academic impact, for papers by Dimitrios Christoulas Breakdown of academic impact, for papers by Nicola Conran Breakdown of academic impact, for papers by Johan Lanng Nielsen Breakdown of academic impact, for papers by Ron Hoffman Breakdown of academic impact, for papers by Shirley D’Sa Breakdown of academic impact, for papers by Wynona Coles Breakdown of academic impact, for papers by Laura Sainati Breakdown of academic impact, for papers by Valeria Maria Pinto
Rankless by CCL
2026